Health Research, Vol. 3, Issue 4, Dec  2019, Pages 1-14; DOI: 10.31058/ 10.31058/

Rubella Seropositivity in Sudanese Children with Type I Diabetes Mellitus

, Vol. 3, Issue 4, Dec  2019, Pages 1-14.

DOI: 10.31058/

Hind TajAlser 1*

1 Department of Immunology, Sudan Academy of Science, Khartoum, Sudan

Received: 9 December 2019; Accepted: 9 December 2019; Published: 16 December 2019

Full-Text HTML | Download PDF | Views 260 | Download 156


Viruses have long been suspected to contribute to the onset of T1D; Rubella virus is a non-segmented,single-stranded RNA enveloped virus that belongs to the togavirus family. It has been implicated in T1D, as patients with congenital syndrome (CRS) had a higher incidence of T1D than the general population. It is objected that to evaluate the sero-prevalence of anti-rubella  IgG antibodies in type 1DM patients compared to non-diabetic  children.A total number of 45 diabetic type 1 patients and 45 as control were enrolled in the study.  Male to female ratio was 1: 1 among the  two groups. Age range  between 6 -18 years with a mean of 12,6  ±3.1   for the  patients and  the  range was 9 -18.   for the control  with a mean 16.5 ± 2.4 The majority of the participants were from Bahri locality.  All the participants declared  no history of rubella infection or vaccination against rubella taken  The result obtained in this study was that more than 75% of the study groups showed   IgG antibodies seropositivity   and insignificant correlation (p= 0.525) was found when comparing the diabetic patients with the control.


Rubella Virus, Diabetes Mellitus (D.M), Children


© 2017 by the authors. Licensee International Technology and Science Press Limited. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


[1] Issabeagloo, E.; Forughi, R.; Taghizadieh, M.; Kermanizadeh, P. Effect of Alcohol on Blood Glucose Levels in Streptozotocin Induced Diabetic Rats. Middle-East Journal of Scientific Research, 2012, 12(3), 290-293.

[2] Albaitushi, A.; Mahmood, T. Viral infections and Diabetes Mellitus. J Biotech Reaserch Center. 2011, 3(5), 29-33.

[3] Sharma, S.; Dwivedi, J.; Swapnil, S. Experimental models of diabetes. Inter.J research Ayurved and pharmacy. 2010, 1(2), 292-301.

[4] Christophe, M.; Filippi and Matthias, G.; Herrath, V. Viral trigger for type 1 diabetes. ADA. 2008, 57(11), 2863-2871.

[5] Neighbors, M.; Tannehill-Jones, R. Childhood diseases and disorders, Human diseases, 3rd Ed; Clifton Park: New York, Delmar, Cengage Learning, USA, 2010, 457-79; ISBN 978-1-4354-2751-8.

[6] Siegel, M.; Fuerst, H.; Guinee, V. Rubella epidemicity and embryopathy. Results of a long-term prospective study. Am. J. Dis. Child. 1971, 121(6), 469-73.

[7] Altman, A.; Szyper-Kravitz, M.; Agmon-Levin, N.; Gilburd, B.; Anaja, J.; Barzilaj, O.; Ram, M.; Bizzaro, N.; Stojanovich, L.; Damoiseaux, J.; Tervaert, J.; Bombardieri,.S.; Amital, H.; Shamis, A.; Shoenfeld, Y. Prevalence of rubella serum antibody in autoimmune diseases. Rev Bras Reumatol. 2012, 52(3), 307-18.

[8] Morgan-Capner, P.; Hambling, A.H.; Coleman, I.J. Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet, 1985, I, 244-6.

[9] Pickering, L.; Baker, C.; Kimberlin, D.; Long, S. Red Book: Report of the Committee on Infectious Diseases, 28th ed.; Elk Grove Village. IL: American Academy of Pediatrics, USA, 2009, 579-84. ISBN 978-1-58110-306-9.

[10] World Health Diabetes: Factsheet N°312. 2013. Available online: (Accessed on 31 October 2015).

[11] Zhang, T.; Mauracher, C.; Mitchell, L.; Tingle, A. Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. J Clin Microbiol, 1992, 30(4), 824-830.

[12] Banatvala J.E, et al. Rubella. Lancet, 2004, 363(9415), 1127–1137.

[13] Watson, J.; Hadler, S.; Dykewicz, C.; Reef, S.; Phillips, L. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998, 47(RR-8), 1-57.

[14] Wolinsky, J.; McCarthy, M. Rubella, In Handbook of Infectious Diseases - Exotic Viral Infections; Porterfield, J.S; Chapman and Hall, London, UK, 1995, 1.

[15] Knip, M.; Veijola, R.; Virtanen, S.M.; Hyöty, H.; Vaarala, O.; Akerblom, H.K. Environmental Triggers and Determinants of Type 1 Diabetes. Diabetes, 2005, 54, S125-S136.

[16] Bluestone, J.; Hrold, K.; Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature, 2010, 464(7293), 1293-1300.

[17] Pociot, F.; Lernmark, A. Genetic risk factors for type 1 diabetes. Lancet, 2016, 387(10035), 2331-2339.

[18] Hirschhorn, J. Genetic epidemiology of type 1 diabetes. Pediatric Diabetes, 2003, 4(2), 87-100.

[19] Fairweather, D.; Rose, N. Type 1 diabetes: virus infection or autoimmune disease? Nat Immunol, 2002, 3 (4), 338–40.

[20] Donner, H.; Rau, H.; Walfish, P.; Braun, J.; Siegmund, T.; Finke, R.; Herwig, J.; Usadel, K.; Badenhoop, K. CTLA4 alanine-17 confers genetic susceptibility to Graves disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 1997, 82(1), 143-6.

[21] Chatzigeorgiou, A.; Harokopos, V.; Mylona-Karagianni, C.; Tsouvalas, E.; Aidinis, V.; Kamper, E. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. ANN. MED. 2010, 42(6), 426-38.

[22] Fujinami, R.; Herrath, M.; Christen, U.; Whitton, J. Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease. Clin Microbiol. 2006, 19(1), 80-94.

[23] Echeverri, A.F.; Tobon, G.J. Autoimmune diabetes mellitus (type 1 A). In Autoimmunity : from bench to beside, 1st ed.; Anaya, J.M.; Shoenfeld, Y.; Rojas – Villarrage, A.; et al. Eds,; El Rosario University Press, Bogota (Colombia), 2013; chapter 29. Available online: (Accessed on 31 October 2014).

[24] Numazaki, K.; Goldman, H.; Seemayer, T.A.; Wong, I.; Wainberg, M.A. Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In vivo, 1999, 4(1), 49-54.

[25] Ramondetti, F.; Sacco, S.; Comeli, M.; Bruno, G.; Falorni, A.; Lannili, A.; d’Annunzio, G.; Lafusco, D.; Sonqini, M.; Toni, S.; Cherubini, V.; Carle, F.; RIDI study group. Type1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin – dependent diabetes registry. Diabetic Medicine, 2012, 29(6), 761-766.

[26] Viskari, H.; Paronen, J.; Kwskinen, P.; Simell, S.; Zawilinska, B.; Zgonniak-Nowosielska, I.; Korhonen, S.; Ilonen, J.; Simeel, O.; Haapola, A.; Knip, M.; Hyoty, H. Humoral β-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol. 2003, 133(3), 378-383.

[27] Ginsberg-Fellner, F.; Witt, M.; Yagihaski, S. Congenital rubella-syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia, 1984, 27, 87-89.

[28] Mary, E.; Ginsberg, F.; Fedun, B.; Taub, F.; Dobersen, M.; McEvoy, R.; Cooper, L.; Notkins, A. Diabetes Mellitus and Autoimmunity in Patients with the Congenital Rubella Syndrome. Oxford Journals.Medicine & Health .Clinical Infectious Diseases, 1985, 7, S170-S176.

[29] Forrest, J.M.; Menser, M.A.; Burgess, J.A. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet. 1971, 2(7720), 332-4.

[30] Kathleen, A.; Joann, A.; Walter, E. Congenital Rubella Syndrome and Diabetes: A Review of Epidemiologic, Genetic and Immunologic Factors. American Annals of the Deaf, 1985, 130(6), 526-532.

[31] George, M.; Johnso, M.; Robert, B.; Tudor. Diabetes Mellitus and Congenital Rubella Infection. MD Am J Dis Child. 1970, 120(5), 453-455.

[32] Hee-Sook, J.; Ji-Won, Y. A New Look at Viruses in Type 1 Diabetes. Diabetes Metabolism Research and Reviews, 2002, 19(1), 8-31.

[33] American Diabetes Association, National Diabetes Statistics Report, 2014. Statistics About Diabetes. Available online: (Accessed on 31 October 2015).

[34] Kawasaki, E.; Eisenbarth, G.S. High-throughput Radio assays for Autoantibodies to Recombinant Autoantigens. Front Biosceinces, 2000, 5, E181-90.

[35] Rabinowe, S.L.; George, K.L.; Loughlin, R.; Soeldner, J.S.; Eisenbarth, G.S. Congenital Rubella. Monoclonal antibody-defined T cell abnormalities in young adults. American Journal of Medical Sciences, 1986, 81, 779-82.

[36] Clarke, W.; Shaver, K.; Bright, G.; Rogol, A.; Nance, W. Autoimmunity in Congenital Rubella Syndrome. The Journal of Pediatrics, 1984, 104, 370-3.

[37] Altobelli, E.; Petrocelli, R.; Verrotti, A.; Valenti, M. Infections and risk of type I diabetes in childhood: a population-based case-control study. Eur J Epidemiol. 2003, 18(5), 425-30.

[38] Hiltunen, M.; Lönnrot, M.; Hyöty, H. Immunisation and type 1 diabetes mellitus: is there a link? Drug Saf. 1999, 20(3), 207-12.

[39] Vial, T.; Descotes, J. Autoimmune diseases and vaccinations. Eur J Dermatol. 2004, 14(2), 86-90.